HCPLive Network

Two-Way Tie for Hypoglycemia, Dementia in Diabetes

TUESDAY, June 11 (HealthDay News) -- For older adults with diabetes mellitus there appears to be a bidirectional correlation between hypoglycemia and dementia, according to research published online June 10 in JAMA Internal Medicine.

Kristine Yaffe, MD, from the University of California in San Francisco, and colleagues prospectively assessed the correlation between hypoglycemia and dementia in a biracial cohort including 783 older adults with diabetes mellitus (mean age, 74.0 years).

During a 12-year follow-up period, the researchers found that 7.8 percent of participants experienced a hypoglycemic event and 18.9 percent developed dementia. The risk of dementia was increased significantly for those who experienced versus those who did not experience a hypoglycemic event (34.4 versus 17.6 percent; multivariate-adjusted hazard ratio, 2.1). Compared with participants who did not develop dementia, those who developed dementia had a significantly greater risk of having a subsequent hypoglycemic event (14.2 versus 6.3 percent; multivariate-adjusted hazard ratio, 3.1). Similar results were seen after further adjustment for stroke, hypertension, myocardial infarction, and cognitive change scores.

"In summary, our results provide evidence for a bidirectional association between severe hypoglycemia and dementia," the authors write. "Hypoglycemia may impair cognitive health, and reduced cognitive function may increase the risk for a hypoglycemic event that could further compromise cognition, resulting in a detrimental cycle."

One author disclosed financial ties to the pharmaceutical industry.

Abstract
Full Text
Editorial

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Isolated systolic hypertension (ISH) in young and middle-aged adults is on the rise. A study in the Journal of the American College of Cardiology found that ISH puts these patients at higher relative risk for heart disease and mortality than their peers with normal blood pressure. That raises the question of whether these younger ISH patients should be getting drug therapy.
Opioids can be effective in controlling back pain, but their use carries risk of complications, misuse, and abuse. Clinicians have to decide when it is a good idea to prescribe them and when it is not.
Avoiding intracranial hemorrhage (ICH) is a major concern for physicians treating patients with anticoagulation drugs. Iatrogenic ICH related to anticoagulants occurs in 0.3% to 1.8% of patients a year who are taking warfarin.
More Reading